NCT06746103

Brief Summary

This is a prospective, multicenter, observational study focusing on assessing and managing pain in patients with metastatic spinal tumors. Pain from spinal metastases adversely impacts quality of life, function, and treatment outcomes. Advances in surgical techniques have shown significant benefits. However, previous studies either lacked nuanced differentiations or simply categorized pain as mechanical or non-mechanical; explaining the highly variable pain outcome measurements in these studies. This study employs the AO Spine Cancer-Related Pain Classification to better categorize neoplastic spinal pain by etiology.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Mar 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Mar 2025Nov 2027

First Submitted

Initial submission to the registry

December 11, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

March 31, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

2.7 years

First QC Date

December 11, 2024

Last Update Submit

December 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity on the Brief Pain Inventory Intensity Scale of four different types of pain caused by the index spinal metastasis, measuring pain on a numeric rating scale from 0 to 10, with 0 meaning no pain and 10 meaning as bad as one can imagine.

    The primary study outcome is the intensity of the four different types of pain caused by the index spinal metastasis, ie, the index pain(s): * Axial non-triggered pain * Axial triggered/mechanical pain * Radicular non-triggered pain * Radicular triggered/mechanical pain

    Baseline and 3 months

Secondary Outcomes (33)

  • Patient Reported Outcome Measure: Michigan Body Map measuring pain location

    Baseline, 1 month, 3 months, and 6 months

  • Patient Reported Outcome Measure: PainDETECT measuring neuropathic pain

    Baseline, 1 month, 3 months, and 6 months.

  • Patient Reported Outcome Measure: BAT measuring breakthrough pain

    Baseline, 1 month, 3 months, and 6 months.

  • Patient Reported Outcome Measure: PROMIS Bank v1.0-Fatigue measuring fatigue

    Baseline, 1 month, 3 months, and 6 months.

  • Patient Reported Outcome Measure: PROMIS Bank v2.0-Physical Function measuring physical function

    Baseline, 1 month, 3 months, and 6 months.

  • +28 more secondary outcomes

Interventions

SurgeryPROCEDURE

Surgery may be instrumented stabilization surgery alone, instrumented stabilization and decompression, or decompression surgery alone.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with metastatic spinal tumors as per eligibility criteria.

You may qualify if:

  • Age 18 years and older
  • Patients diagnosed with metastatic spinal tumors with one index metastatic site that, confirmed by the treating clinicians, is causing spine pain
  • Patients experience at least one type of pain that is of interest of this study, namely, axial non-triggered pain, axial triggered/mechanical pain, radicular non-triggered pain, and radicular triggered/mechanical pain
  • At least one type of the pain experienced has an NRS \> 4 of 10
  • Patients undergoing surgery and/or radiotherapy
  • Surgery may be instrumented stabilization surgery alone, instrumented stabilization and decompression, or decompression surgery alone.
  • Percutaneous screw fixation counts as instrumented stabilization surgery.
  • Any kind of radiotherapy is includable.
  • Ability to provide informed consent according to the IRB/EC defined and approved procedures

You may not qualify if:

  • Estimated survival \< 3 months
  • Patients with more than one symptomatic spine metastasis site
  • o An example is a patient with two metastasis sites: a lumbar metastasis (causing vertebral fracture and epidural compression leading to mechanical lower back pain and static radicular pain to legs) and a cervical metastasis (causing tumor-related pain at the neck).
  • Patients with other sources of pain that may confound the measurement of the primary outcome
  • o An example is a patient with liver metastasis which causes visceral pain that can confound the thoracic spinal pain caused by the spinal metastasis.
  • Cement augmentation, vertebroplasty, kyphoplasty, and other emerging interventions such as local ablative technique
  • Chemotherapy or systemic therapy alone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Surgical Procedures, Operative

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2024

First Posted

December 24, 2024

Study Start

March 31, 2025

Primary Completion (Estimated)

November 30, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

December 24, 2024

Record last verified: 2024-12